Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Real Estate Credit Investments (RECI)
Capital Markets Day
25th Jul 2024
H&T Group
Pawnbroking: the global perspective for H&T
23rd Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Podcast
All
Events
In the media
Insight
MiFID II Monitor
News
Podcast
Tax Advantaged
Video
Select a department
Events
In the media
Insight
MiFID II Monitor
News
Podcast
Tax Advantaged
Video
65: How the leisure sector successfully navigated COVID-19 and will cope with the recession...
13 Dec 2022
64: How the power law affects your investing | Graham Schwikkard of SyndicateRoom
29 Nov 2022
|
By Dr Brian...
63: A new plan to generate secondary liquidity | Rufus Pearl of PlanD
15 Nov 2022
|
By Dr Brian...
62: How companies pivot | Reuben Wilcock of Blackfinch Ventures
01 Nov 2022
|
By Dr Brian...
61: How to choose a VCT or EIS fund | Ewoud Karelse of Evelyn...
18 Oct 2022
|
By Dr Brian...
60: Biotech update and investing | Sunil Shah of o2h Ventures
04 Oct 2022
|
By Dr Brian...
59: Impact companies and their investors | Weedingtech with Boundary Capital and Go Thrift...
20 Sep 2022
|
By Dr Brian...
58: Valuations in venture investing | Dave Foreman of Praetura Ventures
06 Sep 2022
|
By Dr Brian...
57: Lessons from edtech investing | Matthew O’Kane of Nexus Investment Ventures
23 Aug 2022
|
By Dr Brian...
56: Foresight’s acquisition of Downing’s venture businesses | Matt Smith and Jack Eadie of...
09 Aug 2022
|
By Dr Brian...
55: Regional investing | Michael Vassallo of Maven
26 Jul 2022
|
By Dr Brian...
54: How to make ESG work in venture capital | Andrew Noble of Par...
12 Jul 2022
Prev
1
2
3
4
5
6
...
9
Next